Translational Summer School 2020

6 – 10 July 2020

We are delighted to announce that planning  for our third Translational Research Summer School which will be held in July 2020 in Leiden, Netherlands is well underway.
Building on the past two summer schools, both of which received excellent feedback, our residential course will furnish attendees such as researchers and clinicians with a well-rounded knowledge of the translational pathway. Attendees will also benefit from the very latest knowledge available in the neuromuscular community as this course is delivered by key stakeholder in the field.

Areas that were previously covered include…

  • Neuromuscular diseases and current care and management practices
  • Bench to bedside research
  • Challenges for rare disease therapy development and networking solutions
  • Tools of the trade for preclinical research.
  • An introduction to TACT (TREAT-NMD Advisory Committee for Therapeutics) and a TACT mock review session
  • Introduction to clinical trials
  • How the regulatory system works
  • The Industry perspective on drug development for rare diseases
  • Outcome measures used in clinical trials
  • TREAT-NMD tools for clinical trials
  • Biomarkers
  • PROM development
  • Post-marketing

To ensure a high-quality learning environment class sizes are kept deliberately small. With this in mind, we recommend applying promptly to ensure the maximum chance of successfully securing a place at our next Summer School.

Application to attend will open in early 2020!

We look forward seeing some of you in Leiden!

Venue

Leiden
The Netherlands

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission


“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern